In a letter Tuesday to Novo Nordisk's top executives, Sens. Jeanne Shaheen, D-N.H., Raphael Warnock, D-Ga., and Elizabeth Warren, D-Mass., said the company's decision to discontinue Levemir ...

A patient advocacy group has started a campaign to stop Novo Nordisk from following through on a plan to stop making insulin product Levemir, arguing that it could leave some diabetics without an ...

A Utah mother is fighting for her teenage daughter’s access to diabetes medicine. Ruby Smart, 15, has been taking Levemir ...

Novo Nordisk (NYSE:NVO) is a Denmark-based firm that owns drug brands such as Levemir, Tresiba, NovoLog, Novolin R, and Novolin N. Overall, NVO ranks 6th on our list of firms that took a hit on ...

Penfill ® is a pre-filled 3mL glass cartridge designed to be used with Novo Nordisk insulin delivery devices (such as NovoPen ®). This medicine is not addictive. Levemir ® Penfill ® is availab ...

Demographic trends are strengthened by a market shift from human insulin toward modern insulin analogs (such as Novo's Levemir and NovoLog) and now next-generation insulin analogs (Tresiba ...

The firm attributes its lower revenue projections to conservative estimates for Levemir and Victoza, two of Novo Nordisk's products. With an impressive gross profit margin of 84.66% and a P/E ...

Novo Nordisk (NYSE:NVO) is a Denmark-based firm that owns drug brands such as Levemir, Tresiba, NovoLog, Novolin R, and Novolin N. Overall, NVO ranks 6th on our list of firms that took a hit on Friday ...